Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2010/091/002969
CTRI/2010/091/002969
Completed
Phase 3

Ivabradine in controlling tachycardia among critically ill patients - None

Fluid Research Grant Christian Medical CollegeVellore Tamilnadu0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Sinus Tachycardia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Sinus Tachycardia
Sponsor
Fluid Research Grant Christian Medical CollegeVellore Tamilnadu
Enrollment
100
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Fluid Research Grant Christian Medical CollegeVellore Tamilnadu

Eligibility Criteria

Inclusion Criteria

  • •a)Aged above 18 years
  • •b)Sinus rhythm with heart rate above 120 bpm
  • •c) 24 hours of admission to the ICU with a diagnosis of shock.
  • •d)In case of patients admitted with Organophosphorus poisoning, they should have been off atropine for at least 48 hours.

Exclusion Criteria

  • •ICU Physician assessment
  • •Sick sinus syndrome
  • •Sinu\-atrial block
  • •Pacemaker\-dependency
  • •3rd degree AV block
  • •Ongoing fluid/volume loss
  • •On concomitant use of potent CYP3A4 inhibitors:
  • •Azole antifungals (ketoconazole, itraconazole),
  • •Clarithromycin , erythromycin, josamycin, telithromycin,
  • •HIV protease inhibitors (nelfinavir, ritonavir)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Role of Ivabradine in reducing tachycardia induced adverse outcomes in severe septic shockHealth Condition 1: O- Medical and Surgical
CTRI/2022/01/039557Calcutta national medical college
Completed
Not Applicable
Trial of ivabradine for controlling high heart rate control in septic shock.Health Condition 1: null- Septic shock
CTRI/2017/09/009849All India Institute of Medical Sciences New Delhi60
Active, not recruiting
Not Applicable
Ivabradine IN IMPROVING THE EFFECTIVENESS OF THE ENDOTHELIAL FUNCTION IN PATIENTS WITH CAD undergoing coronary angioplasty
EUCTR2012-005359-18-ITIVERSITA' CAMPUS BIOMEDICO
Unknown
Phase 1
Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart FailureDecompensated Heart Failure
NCT02236247University of Sao Paulo50
Completed
Phase 4
Effects of ivabradine for the ventricular rate control in patients with permanent atrial fibrillation and heart failureAtrial fibrilationAtrial Fibrilation&#44Ivabradine&#44Mean ventricular rate
TCTR20160706002Faculty of medicine Endowment Fund for medical research, Chiang Mai university, Thai land32